Search
Select region
Close filter

Moses Zonana

联系信息

+305 569 1014

Moses Zonana draws on his experience in MedTech, digital health, telecom and technology to help clients across a range of industries tackle complex transformation, leadership, and organizational challenges. He is active in Egon Zehnder’s Healthcare and Technology Communications Practices, and he is particularly energized by building resilient, adaptable, cohesive, and purpose-driven teams.

Sustainable organizational success is about people, processes, product, and purpose. I am privileged to work with industry leaders to funnel the right talent to the right leadership roles and contextual purpose to harness the full potential of people.

Before joining the Firm, Moses was an entrepreneur, founding and running several start-ups, including Compliance Meds Technologies, Reliance Meds, TLeMAZ and NetLogistiK.

He earned an MBA from Harvard University and a BA from Rutgers University. Moses is active in Angel Investment Groups and was a member of the Entrepreneurs Organization (South Florida Chapter) for more than 10 years. Outside of work, Moses is an avid squash and tennis player.

联系我们
Send Moses a Message
Browse all
Thought Leadership

全球相关顾问

Isabelle Langlois-Loris

Isabelle Langlois-Loris

Brussels

Isabelle Langlois-Loris offers deep expertise in all talent matters, including executive and board searches, management appraisals, and leadership… 阅读更多

Ellen Garvey-Das

Ellen Garvey-Das

Amsterdam

Ellen Garvey-Das, based in London, is a leading member of Egon Zehnder’s global Private Equity Practice. She advises clients across the spectrum… 阅读更多

Jochen Günnewig

Jochen Günnewig

Düsseldorf

Jochen Günnewig is active in the firm’s Industrial, Services, Financial Officers, Supply Chain, and Board Consulting practices, in addition to the… 阅读更多

Changing language

Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top